0000899243-17-012930.txt : 20170511
0000899243-17-012930.hdr.sgml : 20170511
20170511203039
ACCESSION NUMBER: 0000899243-17-012930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170510
FILED AS OF DATE: 20170511
DATE AS OF CHANGE: 20170511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OCAMPO CHRISTINE
CENTRAL INDEX KEY: 0001280154
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 17836087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-10
0
0001404281
Novus Therapeutics, Inc.
NVUS
0001280154
OCAMPO CHRISTINE
C/O NOVUS THERAPEUTICS, INC.
19900 MACARTHUR BLVD., SUITE 550
IRVINE
CA
92612
0
1
0
0
See Remarks
Common Stock
2017-05-10
4
P
0
10010
9.99
A
21590
D
All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017.
Chief Financial and Compliance Officer
/s/ Ryan A. Murr, as attorney-in-fact for Christine G. Ocampo
2017-05-11